Literature DB >> 24909388

Risk of adenomas with high-risk characteristics based on two previous colonoscopy.

Kang-Heum Suh1, Ja Seol Koo, Jong Jin Hyun, Jungsoon Choi, Jang Soo Han, Seung Young Kim, Sung Woo Jung, Yoon Tae Jeen, Sang Woo Lee, Jai Hyun Choi.   

Abstract

BACKGROUND AND AIM: The recommended intervals between surveillance colonoscopies are based on the most recent examination findings. However, whether the two previous colonoscopies affect second surveillance colonoscopic findings is not established. The aim of this study is to estimate the risk of obtaining high-risk findings (HRF) on the next surveillance colonoscopy using the results of two previous colonoscopies, and to estimate the appropriate time interval for the next surveillance colonoscopy.
METHODS: Among subjects who underwent screening colonoscopy during January 2002-December 2009, patients who underwent second surveillance colonoscopy before June 2012 were enrolled. "No adenoma" was defined as a hyperplastic polyp or no polyp, "low-risk findings (LRF)" as one or two small (< 1 cm) tubular adenomas, and "HRF" as advanced adenoma, cancer, or any sized multiple (≥ 3) adenomas.
RESULTS: Among enrolled 852 subjects, 65 (7.6%) had HRF at second surveillance colonoscopy. Multivariate analysis showed that HRF on second surveillance colonoscopy were associated with male and HRF on screening colonoscopy (all, P < 0.01). In subjects with LRF on first surveillance colonoscopy, HRF on the screening colonoscopy significantly affected the detection of HRF on second surveillance colonoscopy (P < 0.01). Patients with HRF on screening colonoscopy and LRF on the first surveillance colonoscopy had no different risk of HRF on second surveillance colonoscopy from those with HRF on first surveillance colonoscopy (P > 0.05).
CONCLUSIONS: The HRF on second surveillance are significantly associated with previous two colonoscopic results. In patients with LRF on first surveillance, screening colonoscopic findings should be considered to determine the optimal surveillance interval.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  high-risk findings; polypectomy; surveillance colonoscopy

Mesh:

Year:  2014        PMID: 24909388     DOI: 10.1111/jgh.12650

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Gastroenterology       Date:  2020-02-07       Impact factor: 22.682

2.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Gastrointest Endosc       Date:  2020-02-07       Impact factor: 9.427

3.  Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Samir Gupta; David Lieberman; Joseph C Anderson; Carol A Burke; Jason A Dominitz; Tonya Kaltenbach; Douglas J Robertson; Aasma Shaukat; Sapna Syngal; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2020-03       Impact factor: 12.045

4.  Outcomes at follow-up of negative colonoscopy in average risk population: systematic review and meta-analysis.

Authors:  Thomas Heisser; Le Peng; Korbinian Weigl; Michael Hoffmeister; Hermann Brenner
Journal:  BMJ       Date:  2019-11-13

5.  Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies.

Authors:  Munenori Honda; Hideaki Naoe; Ryosuke Gushima; Hideaki Miyamoto; Masakuni Tateyama; Kouichi Sakurai; Yasushi Oda; Yoshitaka Murakami; Yasuhito Tanaka
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.